Loss of 18q and homozygosity for the DCC locus: Possible markers for clinically aggressive squamous cell carcinoma

被引:0
|
作者
Kelker, W
VanDyke, DL
Worsham, MJ
Christopherson, PL
James, CD
Conlon, MR
Carey, TE
机构
[1] UNIV MICHIGAN, CTR CANC, LAB HEAD & NECK CANC BIOL, ANN ARBOR, MI 48109 USA
[2] HENRY FORD HOSP, DETROIT, MI 48202 USA
[3] EMORY UNIV, WINSHIP CANC CTR, ATLANTA, GA 30322 USA
关键词
squamous cell carcinoma; homozygosity; loss; DCC locus; chromosomes;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Karyotyping and polymorphisms within the DCC (deleted in colon cancer) locus (18q21) were used to analyze loss of chromosome 18 in squamous cell carcinomas (SCC). Tumors from 26 patients (including 7 for whom matched tumor and normal DNA samples were available) were examined for heterozygosity within DCC. Of the seven normal-tumor combinations, four were informative. Two of these had loss of heterozygosity (LOH) at DCC. For 19 SCC tumor cultures normal tissue was not available. These were scored only as homozygous or heterozygous. The majority were homozygous. Only 3/19 (15%) were heterozygous. In contrast, in a panel of normal blood samples the majority, 11/16 (69%), were heterozygous. Allelic zygosity was concordant with the chromosome 18 content in the 16 armors that were also karyotyped. Tumors fr om 40 patients 37 that were karyotyped and three that were informative at the DCC locus, were assessed for loss of chromosome 18 and patient survival. Loss of part or all of chromosome 18 occurred in tumors from 25. Twenty-seven of the 40 patients have died and 13 are alive. There was strong association between loss of 18 and overall survival. Of those who are alive only 5/13 (38%) had loss of 18, whereas among those who have died 20/27 (74%) had loss of 18. By chi(2) analysis the association of loss of 18 and death from cancer was significant (p>0.01). The high frequency of chromosome 18 loss in SCC suggests that this region contains one or more tumor suppressor genes important in the clinical behavior of SCC. DCC is one candidate, brit other regions of loss not including the DCC locus indicate that chromosome 18 probably contains more than one tumor suppressor locus. Prospective studies of chromosome 18 loss as a single prognostic indicator are strongly indicated in this tumor type since loss in early stage armors might indicate a need for more aggressive therapy than would be given on the basis of staging alone.
引用
收藏
页码:2365 / 2372
页数:8
相关论文
共 50 条
  • [21] Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
    Weronika Szukala
    Agata Lichawska-Cieslar
    Roza Pietrzycka
    Maria Kulecka
    Izabela Rumienczyk
    Michal Mikula
    Iwona Chlebicka
    Piotr Konieczny
    Katarzyna Dziedzic
    Jacek C Szepietowski
    Giulia Fontemaggi
    Janusz Rys
    Jolanta Jura
    Journal of Experimental & Clinical Cancer Research, 40
  • [22] A clinicopathological and immunohistochemical study of gastric cancer with squamous cell carcinoma components: A clinically aggressive tumor
    Saito, Shin
    Hosoya, Yoshinori
    Morishima, Kazue
    Ui, Takashi
    Haruta, Hidenori
    Kurashina, Kentaro
    Meguro, Yoshiyuki
    Zuiki, Toru
    Sata, Naohiro
    Fujii, Hirofumi
    Matsubara, Daisuke
    Niki, Toshiro
    Lefor, Alan T.
    Yasuda, Yoshikazu
    JOURNAL OF DIGESTIVE DISEASES, 2012, 13 (08) : 407 - 413
  • [23] Refinement of regions with allelic loss on chromosome 18p11.2 and 18q12.2 in esophageal squamous cell carcinoma
    Karkera, JD
    Ayache, S
    Ransome, RJ
    Jackson, MA
    Elsayem, AF
    Sridhar, R
    Detera-Wadleigh, SD
    Wadleigh, RG
    CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3565 - 3569
  • [24] TREATMENT OF AGGRESSIVE SQUAMOUS CELL CARCINOMA IN PATIENTS WITH EPIDERMOLYSIS BULLOSA: MITOCHONDRIA AS A POSSIBLE TARGET
    Welponer, Tobias
    Trattner, Lisa
    Tockner, Birgit
    Reichl, Victoria
    Kaufmann, Anna
    Kienzl, Melanie
    Felder, Thomas
    Aminzadeh-Gohari, Sepideh
    Feichtinger, Rene
    Lang, Roland
    Bauer, Johann W.
    Reichelt, Julia
    Kofler, Barbara
    Guttmann-Gruber, Christina
    Hofbauer, Josefina Pinon
    ACTA DERMATO-VENEREOLOGICA, 2020, 100 : 52 - 53
  • [25] FREQUENT ALLELIC LOSSES ON CHROMOSOMES 2Q, 18Q, AND 22Q IN ADVANCED NONSMALL CELL LUNG-CARCINOMA
    SHISEKI, M
    KOHNO, T
    NISHIKAWA, R
    SAMESHIMA, Y
    MIZOGUCHI, H
    YOKOTA, J
    CANCER RESEARCH, 1994, 54 (21) : 5643 - 5648
  • [26] A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene
    Schneider, S. S.
    Schick, C.
    Fish, K. E.
    Miller, E.
    Proceedings of the National Academy of Sciences of the United States of America, 92 (08):
  • [27] Systematic screening of chromosome 18 for loss of heterozygosity in esophageal squamous cell carcinoma
    Karkera, JD
    Balan, KV
    Yoshikawa, T
    Lipman, TO
    Korman, L
    Sharma, A
    Patterson, RH
    Sani, N
    Detera-Wadleigh, SD
    Wadleigh, RG
    CANCER GENETICS AND CYTOGENETICS, 1999, 111 (01) : 81 - 86
  • [28] Frequent loss of the long arm of chromosome 18 in esophageal squamous cell carcinoma
    Ando, Takuya
    Ishiguro, Hideyuki
    Kimura, Masahiro
    Mitsui, Akira
    Mori, Yoichiro
    Sugito, Nobuyoshi
    Tomoda, Keisuke
    Mori, Ryota
    Harada, Koshiro
    Katada, Takeyasu
    Ogawa, Ryo
    Fujii, Yoshitaka
    Kuwabara, Yoshiyuki
    ONCOLOGY REPORTS, 2007, 17 (05) : 1005 - 1011
  • [29] Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus
    Makino, T.
    Yamasaki, M.
    Takeno, A.
    Shirakawa, M.
    Miyata, H.
    Takiguchi, S.
    Nakajima, K.
    Fujiwara, Y.
    Nishida, T.
    Matsuura, N.
    Mori, M.
    Doki, Y.
    BRITISH JOURNAL OF CANCER, 2009, 101 (08) : 1298 - 1306
  • [30] Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus
    T Makino
    M Yamasaki
    A Takeno
    M Shirakawa
    H Miyata
    S Takiguchi
    K Nakajima
    Y Fujiwara
    T Nishida
    N Matsuura
    M Mori
    Y Doki
    British Journal of Cancer, 2009, 101 : 1298 - 1306